Lessons from a Measles Outbreak in a Military School: Rapid Response and Surveillance Gaps in Sattahip District, Chonburi Province, Thailand, 2025
DOI:
https://doi.org/10.59096/osir.v19i1.278989Keywords:
measles, outbreak investigation, military school, surveillance, ThailandAbstract
Objectives: To confirm a measles outbreak in a military school in Sattahip District, Chonburi Province, Thailand, describe its epidemiologic characteristics, identify associated risk factors, and assess surveillance performance and response timeliness.
Methods: A descriptive and analytical field investigation was conducted among 374 cadets and staff from 30 Jun to 31 Aug 2025. Data were collected through case interviews, environmental assessments, record reviews, and laboratory testing. A retrospective cohort study was performed to identify risk factors. Hospital reporting performance was evaluated, and outbreak response timeliness was assessed using the WHO 7-1-7 detect–notify–respond framework.
Results: Thirty-two measles cases were identified (attack rate 8.6%), all among male cadets. Two waves of transmission occurred, first among second-year cadets and later among first-year cadets. Laboratory testing confirmed measles virus genotype D8 (DSID 9587), genetically related to strains previously detected in the district. Sharing a bathroom with a symptomatic individual (adjusted odds ratio (AOR) 3.12; 95% confidence interval (CI) 1.17–8.33) and close contact with a measles case (AOR 2.31; 95% CI 1.02–5.22) were risk factors, while leaving the school premises was protective (AOR 0.34; 95% CI 0.15–0.74). Outbreak response immunization achieved 100% coverage among cadets and staff and likely interrupted transmission within two incubation periods. Facility-based surveillance evaluation showed low reporting sensitivity (1.04%), indicating underreporting of clinically compatible cases. Although the overall response met the 7-1-7 timeliness targets, delays in symptom reporting and operational constraints were observed.
Public Health Recommendations: Strengthening measles surveillance sensitivity, improving early case reporting, and ensuring rapid outbreak response immunization are essential to prevent transmission in closed institutional settings.
References
World Health Organization. Measles fact sheet. Geneva: World Health Organization; 2024.
World Health Organization. Measles vaccines: WHO position paper, April 2017. Wkly Epidemiol Rec. 2017;92(17):205–28.
Centers for Disease Control and Prevention (US). Measles: for healthcare professionals. Atlanta: Centers for Disease Control and Prevention; 2023.
Moss WJ. Measles. Lancet. 2017;390(10111):2490–502. doi: 10.1016/S0140-6736(17)31463-0.
Measles & Rubella Partnership. Measles and rubella strategic framework 2021–2030: midterm review [Internet]. Baltimore (MD): Measles & Rubella Initiative; 2026 Jan [cited 2026 Feb 11]. 44 p. <https://measlesrubellapartnership.org/wp-content/uploads/2026/01/Measles-and-Rubella-Strategic-Framework-2021-2030-Midterm-Review.pdf>
World Health Organization. Surveillance standards for vaccine-preventable diseases. 2nd ed. Geneva: World Health Organization; 2018.
Department of Disease Control, Thailand Ministry of Public Health. Annual country report on progress toward measles and rubella elimination 2025 (reporting year 2024). Nonthaburi: Department of Disease Control; 2025.
World Health Organization. Manual for the laboratory-based surveillance of measles, rubella, and congenital rubella syndrome. 3rd ed. Geneva: World Health Organization; 2018.
World Health Organization. Measles outbreak investigation and response: field guide. Geneva: World Health Organization; 2017.
Angsuwatcharakon P, Meengoen K, Tiawilai T, Semprawat W, Suphanchaimat R. Measles surveillance evaluation under the measles elimination program in Ratchaburi Hospital and Photharam Hospital, Ratchaburi Province, Thailand, 2024. Wkly Epidemiol Surveill Rep. 2025;56(10):e5570. doi:10.59096/wesr.v56i10.5570.
Frieden TR, Lee CT, Bochner AF, Buissonniere M, McClelland A. 7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics. Lancet. 2021 Aug 14;398(10300):638–40. doi:10.1016/S0140-6736(21)01250-2.
Sphere Association. The Sphere handbook: humanitarian charter and minimum standards in humanitarian response. 4th ed. Geneva: Sphere Association; 2018.
Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, et al. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis. 2011 Jul;204(Suppl 1):S514–23. doi:10.1093/infdis/jir118.
World Health Organization. Genetic diversity of wild-type measles viruses and the global measles nucleotide surveillance database (MeaNS). Wkly Epidemiol Rec. 2015 Jul 24;90(30):373-80.
Bloch AB, Orenstein WA, Ewing WM, Spain WH, Mallison GF, Herrmann KL, et al. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics. 1985 Apr;75(4):676–83. doi:10.1542/peds.75.4.676.
Remington PL, Hall WN, Davis IH, Herald A, Gunn RA. Airborne transmission of measles in a physician’s office. JAMA. 1985;253(11):1574–7. doi:10.1001/jama.1985.03350350068022.
Wanlapakorn N, Wasitthankasem R, Vichaiwattana P, Auphimai C, Yoocharoen P, Vongpunsawad S, et al. Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey. PLoS One. 2019 Nov 26;14(11):e0225606. doi:10.1371/journal.pone.0225606.
Puthanakit T, Anugulruengkitt S, Angsuwatcharakon P, Bunjoungmanee P, Kowitdamrong E, Primsirikunawut A, et al. Low measles seropositivity rate among Thai adolescents in the Thai National Immunization Program. Vaccines (Basel). 2022 Aug 6;10(8):1269. doi:10.3390/vaccines10081269.
LeBaron CW, Beeler J, Sullivan BJ, Forghani B, Bi D, Beck C, et al. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med. 2007 Mar;161(3):294-301. doi:10.1001/archpedi.161.3.294.
Phiriyasart F, Seerako A, Suksridaeng T, Khwankerd R, Nihok S, Ninlakan N, et al. Turning the tide on measles: EOC-led response and school-based vaccination in Narathiwat Province’s outbreak, 2024–2025. OSIR. 2025 Sep;18(3):133–43. doi:10.59096/osir.v18i3.274693.
Griffin DE. Measles Vaccine. Viral Immunol. 2018 Mar;31(2):86-95. doi:10.1089/vim.2017.0143.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Outbreak, Surveillance, Investigation & Response (OSIR) Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
